Veterinary Medicines

Cardalis 5 mg benazepril hydrochloride + 40 mg spironolactone - Chewable Tablet

Authorised
  • Benazepril hydrochloride
  • Spironolactone
Download as PDF

Product identification

Medicine name:
Cardalis 5 mg benazepril hydrochloride + 40 mg spironolactone - Chewable Tablet
Active substance:
  • Benazepril hydrochloride
  • Spironolactone
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    5.00
    milligram(s)
    /
    1.00
    Tablet
  • Spironolactone
    50.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09BA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Bottle (HDPE), Package_size:90 tablets
  • Packaging:Bottle (HDPE), Package_size:30 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CEVA Santé Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Catalent Germany Schorndorf GmbH
  • Ceva Sante Animale
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 26/05/2023
Download
Bulgarian (PDF)
Published on: 26/05/2023
Download
Croatian (PDF)
Published on: 26/05/2023
Download
Czech (PDF)
Published on: 26/05/2023
Download
Danish (PDF)
Published on: 26/05/2023
Download
Dutch (PDF)
Published on: 26/05/2023
Download
Estonian (PDF)
Published on: 26/05/2023
Download
Finnish (PDF)
Published on: 26/05/2023
Download
French (PDF)
Published on: 26/05/2023
Download
German (PDF)
Published on: 26/05/2023
Download
Greek (PDF)
Published on: 26/05/2023
Download
Hungarian (PDF)
Published on: 26/05/2023
Download
Icelandic (PDF)
Published on: 26/05/2023
Download
Italian (PDF)
Published on: 26/05/2023
Download
Latvian (PDF)
Published on: 26/05/2023
Download
Lithuanian (PDF)
Published on: 26/05/2023
Download
Maltese (PDF)
Published on: 26/05/2023
Download
Norwegian (PDF)
Published on: 26/05/2023
Download
Polish (PDF)
Published on: 26/05/2023
Download
Portuguese (PDF)
Published on: 26/05/2023
Download
Romanian (PDF)
Published on: 26/05/2023
Download
Slovak (PDF)
Published on: 26/05/2023
Download
Slovenian (PDF)
Published on: 26/05/2023
Download
Spanish (PDF)
Published on: 26/05/2023
Download
Swedish (PDF)
Published on: 26/05/2023
Download

ema-puar-cardalis-v-2524-par-en.pdf

English (PDF)
Published on: 17/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."